These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 36292945)
41. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461 [TBL] [Abstract][Full Text] [Related]
42. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model. Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707 [TBL] [Abstract][Full Text] [Related]
43. Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model. Moon M; Jung ES; Jeon SG; Cha MY; Jang Y; Kim W; Lopes C; Mook-Jung I; Kim KS Aging Cell; 2019 Feb; 18(1):e12866. PubMed ID: 30515963 [TBL] [Abstract][Full Text] [Related]
44. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Devi L; Ohno M Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928 [TBL] [Abstract][Full Text] [Related]
45. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice. Devi L; Ohno M Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043 [TBL] [Abstract][Full Text] [Related]
46. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease. Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615 [TBL] [Abstract][Full Text] [Related]
48. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice. Ou-Yang MH; Van Nostrand WE J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129 [TBL] [Abstract][Full Text] [Related]
49. Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease. Mariani MM; Malm T; Lamb R; Jay TR; Neilson L; Casali B; Medarametla L; Landreth GE Sci Rep; 2017 Feb; 7():42270. PubMed ID: 28205585 [TBL] [Abstract][Full Text] [Related]
50. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease. Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978 [TBL] [Abstract][Full Text] [Related]
51. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Sadleir KR; Eimer WA; Cole SL; Vassar R Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526 [TBL] [Abstract][Full Text] [Related]
52. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
53. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology. Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893 [TBL] [Abstract][Full Text] [Related]
54. Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease. Han F; Zhao J; Zhao G J Alzheimers Dis; 2021; 84(4):1551-1562. PubMed ID: 34690137 [TBL] [Abstract][Full Text] [Related]
55. Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice. Gray NE; Zweig JA; Caruso M; Zhu JY; Wright KM; Quinn JF; Soumyanath A Mol Cell Neurosci; 2018 Dec; 93():1-9. PubMed ID: 30253196 [TBL] [Abstract][Full Text] [Related]
56. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525 [TBL] [Abstract][Full Text] [Related]
57. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease. Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907 [TBL] [Abstract][Full Text] [Related]
58. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model. Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926 [TBL] [Abstract][Full Text] [Related]
59. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Devi L; Ohno M Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882 [TBL] [Abstract][Full Text] [Related]
60. WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. Wang Z; Cao M; Xiang H; Wang W; Feng X; Yang X ACS Chem Neurosci; 2019 Dec; 10(12):4787-4799. PubMed ID: 31697472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]